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The type VI secretion system (T6SS) is a virulence
mechanism common to several Gram-negative path-
ogens. InVibriocholerae,VgrG-1 is required forT6SS-
dependent secretion. VgrG-1 is also secreted by
T6SS and displays a C-terminal actin crosslinking
domain (ACD). Using a heterologous reporter enzyme
in place of the ACD, we show that the effector
and secretion functions of VgrG-1 are genetically
dissociable with the ACD being dispensable for
secretion but required for T6SS-dependent pheno-
types. Furthermore, internalization of bacteria is
required for ACD translocation into phagocytic target
cells. Inhibiting bacterial uptake abolishes actin
crosslinking, while improving intracellular survival
enhances it. Otherwise resistant nonphagocytic cells
become susceptible to T6SS-mediated actin cross-
linking when engineered to take up bacteria. Our
results support a model for translocation of VgrG
C-terminal effector domains into target cell cytosol
by a process that requires trafficking of bacterial cells
intoanendocyticcompartmentwhere translocation is
triggered by an unknown signal.
INTRODUCTION
Vibrio cholerae is a Gram-negative pathogen that causes the
diarrheal disease cholera. It is a diverse species that includes
over 200 serogroups, including O1 and O139 strains that cause
epidemic and pandemic disease and non-O1/non-O139 strains
that more typically cause sporadic outbreaks of gastroenteritis
or extraintestinal infections (Rahman et al., 2008). The diversity
displayed by V. cholerae is reflective of the range of environ-
ments it inhabits, including aquatic environments with their
associated organisms (Abd et al., 2005; Chiavelli et al., 2001;
Rawlings et al., 2007) and also the environment within a human
host. V. cholerae has acquired a variety of horizontally trans-
ferred elements encoding human virulence factors, including
the CTX phage encoding cholera toxin (Waldor and Mekalanos,
1996) and a chromosomal island encoding a toxin-coregulated
pilus and other intestinal colonization factors (Everiss et al.,234 Cell Host & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevie1994; Taylor et al., 1987). However, virtually all strains of
V. cholerae, including both clinical and environmental isolates,
encode the genes for well-conserved ‘‘accessory virulence
factors’’ whose role in human disease is less clear, but which
may play essential roles in the environmental fitness of V. chol-
erae and thus its transmission in natural settings. These include
HlyA hemolysin (Manning et al., 1984), HapA hemagglutinin/
protease (Wu et al., 1996), and RtxA toxin (Fullner and Mekala-
nos, 2000). Together, these three virulence factors are thought
to contribute to long-term colonization of adult mice (Olivier
et al., 2007), but their role in human disease has not been fully
evaluated. The type III secretion system islands (Tam et al.,
2007) and the recently identified type VI secretion system
(T6SS) (Pukatzki et al., 2006) are also virulence factors that
are present in clinical and environmental strains of V. cholerae.
All these products and gene clusters are associated with
toxicity for eukaryotic cells and therefore may play a role in
human disease or other pathobiological interactions with envi-
ronmental organisms.
Genes encoding a putative T6SS are present in nearly 25% of
all sequenced Gram-negative bacterial species and are mainly
restricted to pathogens (Bingle et al., 2008). T6SS has been
implicated in virulence in V. cholerae (Pukatzki et al., 2006),
Pseuodomonas aeruginosa (Mougous et al., 2006), Edwardsiella
tarda (Rao et al., 2004; Zheng and Leung, 2007), Burkholderia
species (Aubert et al., 2008; Pilatz et al., 2006; Schell et al.,
2007), and Aeromonas hydrophila (Suarez et al., 2008), among
others. A T6SS is defined by a canonical group of 15–20 genes,
and secretion via this pathway requires orthologs of conserved
T6SS components, which include IcmF and DotU (Pukatzki
et al., 2006; Zheng and Leung, 2007), outer membrane lipopro-
tein SciN (Aschtgen et al., 2008), interacting pair VipA/MglA
and VipB/MglB (de Bruin et al., 2007), and ClpV (Bonemann
et al., 2009). Also genetically or functionally associated with
T6SS clusters are hcp and vgrG genes. In V. cholerae, Hcp
and VgrG proteins are both required for T6SS-dependent secre-
tion and are themselves secreted in a T6SS-dependent fashion
(Pukatzki et al., 2006). Thus, deletion of hcp-1 and hcp-2 in
V. cholerae results in a secretion defect of VgrG proteins
(Pukatzki et al., 2006), and deletion of vgrG-1 or vgrG-2 results
in a secretion defect of Hcp (Pukatzki et al., 2007). This reciprocal
requirement for secretion suggests that Hcp and VgrG are
secretion substrates that are transported through a putative core
T6SS complex and could also comprise components of anr Inc.
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off from bacterial cells.
In vitro secretion ofHcphasbeenobserved inmanyT6SS-con-
taining bacterial species (Aschtgen et al., 2008; Dudley et al.,
2006; Mattinen et al., 2007; Mougous et al., 2006; Pukatzki
et al., 2006; Schell et al., 2007; Suarez et al., 2008; Wu et al.,
2008; Zheng and Leung, 2007), but secretion of VgrG homologs
has been reported for only several of these organisms. EvpI is
a VgrG ortholog whose secretion by Edwardsiella tarda requires
many of the proteins found in its T6SS locus, and secretion of
Hcp and VgrG is also mutually dependent in E. tarda (Zheng
and Leung, 2007). VgrG ortholog ECA3427 is secreted by Pecto-
bacterium atrosepticum (Mattinen et al., 2007), and expression of
five VgrG orthologs and various other T6SS components is regu-
lated by quorum sensing in planta or exposure to host extracts
(Liu et al., 2008; Mattinen et al., 2007; Mattinen et al., 2008).
VgrG-1 is required for T6SS-dependent cytotoxic effects of
V. cholerae on eukaryotic cells, including Dictyostelium discoi-
deum amoebae and J774 macrophages (Pukatzki et al., 2007,
2006). The actin crosslinking domain (ACD) at the C terminus
of VgrG-1 is closely homologous to the ACD domain present
within a secreted toxin of V. cholerae called RtxA (Fullner and
Mekalanos, 2000; Sheahan et al., 2004), which inhibits actin
polymerization by catalyzing intramolecular isopeptide bond
formation between E270 and K50 residues of monomeric actin
(Kudryashov et al., 2008). The appearance of covalently cross-
linked actin in J774 cells incubated with T6SS+ RtxA but not
with T6SS RtxA V. cholerae provides strong evidence that
the ACD of VgrG-1 can enter target cells by a T6SS-dependent
process. Concentrated supernatants containing T6SS-secreted
substrates and purified, enzymatically active VgrG-1 do not
crosslink actin in host cells, suggesting that contact between
V. cholerae and the target cell is required for this translocation
mechanism (Pukatzki et al., 2007).
Bioinformatic analysis predicts that VgrGs are homologs of the
bacteriophage T4 cell-puncturing device called the ‘‘tail spike’’
(Pukatzki et al., 2007). This complex is used by T4 bacteriophage
to puncture the bacterial cell envelope during infection and is
composed of a (gp5)3-(gp27)3 complex that adopts a needle
shape with a central channel (Kanamaru et al., 2002). The
N-terminal region of a VgrG ortholog from uropathogenic E. coli
has since been crystallized and corresponds to gp27 (Leiman
et al., 2009). VgrG proteins are fusion proteins between gp27-
and gp5-like domains and are predicted to form a similar trimeric
structure. Consistent with this model, interactions between
VgrG-1, -2, and -3 have been demonstrated in supernatant fluids
of V. cholerae V52 (Pukatzki et al., 2007). Many VgrG proteins in
other T6SS+ bacterial species contain various C-terminal
domains that correspond to the position of the ACD of VgrG-1,
but translocation of these putative effector domains and their
cognate VgrG proteins has not been reported.
Here we report that the effector and secretion functions of
VgrG-1 can be genetically dissociated. We find that the ACD is
necessary for T6SS-dependent host cell cytotoxicity and impair-
ment of phagocytosis. Furthermore, the ACD is not required for
secretion and can be substituted with a heterologous reporter
enzyme that is similarly secreted and translocated into target
cells. In studying the mechanism of VgrG-1 translocation into
target cells, we find that this process requires endocytosis ofCell HV. cholerae cells, and the same requirements exist for a heterol-
ogous reporter enzyme. Our results support a model for the
translocation of C-terminal effector domains of VgrG proteins
into the cytosol of target cells by a process that requires traf-
ficking of bacterial cells into an endocytic compartment, where
translocation is triggered by an unknown signal.
RESULTS
VgrG-1ACD IsDispensable for Secretion but Is Required
for T6SS-Mediated Host Cell Cytotoxic Effects
VgrG-1 is the first secreted T6SS protein with demonstrated
effector function, and vgrG-1 mutant ATM-4 is phenotypically
avirulent toward J774 cells and Dictyostelium discoideum
(Figures 1D–1F). However, this mutation impairs secretion of
the other T6SS secretion substrates (Figure 1A). To dissociate
the effector and structural apparatus roles of VgrG-1, we con-
structed strain ATM-6, a V. cholerae V52 strain that lacks the
ACD of vgrG-1. In this strain, endogenous vgrG-1 is replaced
with a truncated vgrG-1 gene that encodes for amino acids
1–715 and contains a VSV-G epitope tag in place of the ACD.
ATM-6 was able to secrete the truncated VgrG-1 and the other
known T6SS substrates, VgrG-2, VgrG-3, and Hcp, at levels
comparable to its parental T6SS+ RtxA strain, ATM-1
(Figure 1A). Although competent for secretion, ATM-6 is pheno-
typically avirulent to J774 cells and to D. discoideum. ATM-6
does not induce actin crosslinking (Figure 1B) and does cause
cell rounding of J774 macrophages (data not shown) like
ATM-1. It does not alter cellular actin morphology, as seen after
exposure of J774 cells to ATM-1 or ATM-2, which is a T6SS
RtxA+ strain that can crosslink actin (Figure 1D). Transient expo-
sure to ATM-1 causes host cell death that occurs over the span
of several days, and lysis can bemonitored bymeasuring lactate
dehydrogenase (LDH) release 1 day after exposure (Figure 1C).
Host cells similarly exposed to ATM-6 or ATM-3—a strain that
lacks rtxA and vasK, an icmF homolog required for T6SS function
(Figure 1A)—do not cause host cell lysis (Figure 1C), and recover
to proliferate normally (data not shown). Additionally, ATM-6 is
not virulent toward D. discoideum, which is demonstrated by
the appearance of D. discoideum plaques that form on a lawn
of ATM-6 (Figure 1E), and this plaque formation occurs at levels
comparable to Klebsiella aerogenes, a commonly used feeder
strain for D. discoideum (Figure 1F). These data indicate that
the ACD is likely the critical translocated effector domain for
T6SS-mediated phenotypes observed in host cells.
T6SS-Mediated Actin Crosslinking Requires
Endocytosis of V. cholerae into Host Cells
J774macrophagesandD.discoideumamoebaearebothphago-
cytic cell types that are sensitive to V. cholerae T6SS-mediated
cytotoxicity. To determine whether phagocytic activity contrib-
utes to host cell sensitivity, we surveyed a panel of cell lines for
their ability to internalize V. cholerae and for their sensitivity to
RtxA and T6SS-mediated actin crosslinking (Figures 2A and
2B). Internalization was measured by assaying for V. cholerae
cells protected from gentamicin, an antibiotic impermeable to
host cells (Isberg and Falkow, 1985). HEp-2, A549, and Henle-
407 cells are epithelial cell lines that did not measurably take up
V52 strains. Similarly, 3T3 cells are fibroblast cells that also doost & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevier Inc. 235
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was crosslinked efficiently, indicating that these cell lines were
fully sensitive to RtxA-mediated actin crosslinking. However,
when incubated with ATM-1, host cell actin remained in mono-
meric form, indicating a resistance to T6SS-mediated actin
crosslinking (Figure 2B). In contrast, two different macrophage
cells lines, J774 and RAW 264.7, both internalized ATM-1 and
ATM-3 (Figure 2A) and all other V52 strains listed in Table 1 to
similar levels (data not shown), except for ATM-2, which is dis-
cussed below. Both macrophage cell lines are sensitive to
T6SS-mediated actin crosslinking (Figure 2B).
To determine whether J774 cells remain sensitive to T6SS
actin crosslinking if internalization is inhibited, incubations
were performed in the presence of cytochalasin D, which inhibits
phagocytosis by inhibiting actin polymerization, resulting in
depolymerized actin filaments. Cytochalasin D had little effect
on RtxA-mediated actin crosslinking, as has been previously
reported (Fullner andMekalanos, 2000). In contrast, T6SS-medi-
ated actin crosslinking was abolished (Figure 3A). Inhibition of
Figure 1. The ACD of VgrG-1 Is Required for
Host Cell Phenotypes
(A) Western blots of pellet and supernatant frac-
tions of various V52 strains.
(B) Western blot of host cell actin from J774 cells
incubated with various V52 strains at an moi of
10 for 2 hr.
(C) Supernatants of J774 cells were analyzed for
LDH release one day after exposure to V. cholerae.
Values are from triplicate wells and are expressed
as percentage of LDH released from lysed mock-
treated cells. Error bars indicate ± one SD.
(D) Fluorescence microscopy of cells visualizing
actin with rhodamine phalloidin (red) and nuclei
with DAPI (blue). Scale bar indicates 10 mm.
(E) Dictyostelium discoideum plaque assay with
various V52 strains.
(F) Quantification of plaque formation normalized
to plaque formation on K. aerogenes.
bacterial uptake by cytochalasin D was
verified by gentamicin protection assay
(Figure 3B). Furthermore, cytochalasin D
had no effect on the catalytic activity of
VgrG-1 ACD in vitro (Figure 3C). Thus,
the ability of cytochalasin D to inhibit
VgrG-1-mediated actin crosslinking indi-
cates that bacterial internalization is likely
required for delivery of the ACD into the
target cell cytosol.
Inhibition of Endosomal
Acidification Improves Intracellular
Viability of V. cholerae, Resulting
in Increased T6SS-Mediated
Actin Crosslinking
A variety of bacterial toxins ‘‘sense’’ their
internalization by target cells by under-
going conformational changes induced
by endosomal acidification (Glomski
et al., 2002; Qa’Dan et al., 2000). To determine whether endoso-
mal pH triggers T6SS-mediated translocation of the ACD into
target cells, we incubated J774 cells with V. cholerae in the pres-
ence of bafilomycin A, a specific inhibitor of vacuolar ATPases
(Yoshimori et al., 1991). To exaggerate the effects of bafilomycin
A on intracellular bacteria, a time course of J774 cells exposed to
V. cholerae at a low multiplicity of infection (moi) was performed.
Higher order actin multimers formed more quickly and were
more abundant in incubations with bafilomycin A-treated cells
compared to untreated cells (Figure 4A). Because this drug
does not affect in vitro actin crosslinking by VgrG-1 (Figure 4D)
and is not known to affect rates of endocytosis, the effect of ba-
filomycin A on actin crosslinking is likely due to efficient inhibition
of phagosome acidification. This would have a protective effect
on V. cholerae, since it is an acid-sensitive organism (Merrell and
Camilli, 1999), resulting in increased translocation of ACD.
Indeed, we observed a significant increase in the number of
intracellular bacteria in incubations performed in the presence
of bafilomycin A (Figure 4B). This effect is abrogated by236 Cell Host & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevier Inc.
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(Figures 4B and 4C). Furthermore, translocation apparently
requires active bacterial protein synthesis after internalization,
given that chloramphenicol blocks the appearance of cross-
linked actin in J774 cells exposed to ATM-1 (data not shown).
Enhancement of actin crosslinking by bafilomycin A is thus
consistent with its ability to improve bacterial viability and func-
tion by maintaining a neutral vacuolar pH rather than enhancing
ACD translocation per se.
Translocation of VgrG-1-Bla Fusion Proteins
into J774 Cells
Many VgrG orthologs in other T6SS+ bacteria display C-terminal
extension domains, which might correspond to effector domains
Figure 2. T6SS-Mediated Actin Crosslink-
ing Correlates with Endocytic Uptake into
Host Cells
(A) Gentamicin protection assay of various host
cell lines exposed to various V52 strains at an
moi of 10 for 1 hr, followed by gentamicin treat-
ment and enumeration of intracellular bacteria.
Values are of triplicate wells and are expressed
as percentage of initial inoculum recovered. Error
bars indicate ± one SD.
(B) Actin crosslinking in host cells detected by
western blot after exposure to various V52 strains
at an moi of 10 for 2 hr.
Table 1. Bacterial Strains Constructed for this Study
Strain Genotype
ATM-1 V52 DrtxAa DhlyAa DhapAa
ATM-2 V52 DhlyA DhapA DvasKb
ATM-3 V52 DrtxA DhlyA DhapA DvasK
ATM-4 V52 DrtxA DhlyA DhapA DvgrG-1b
ATM-5 V52 DrtxA DhlyA DhapA Dhcp-1b Dhcp-2b
ATM-6 V52 DrtxA DhlyA DhapA vgrG-1 DACD::VSV-Gc
ATM-7 V52 DrtxA DhlyA DhapA vgrG-1::blac
ATM-8 V52 DrtxA DhlyA DhapA DvasK vgrG-1::bla
ATM-9 V52DrtxADhlyADhapADhcp-1Dhcp-2 vgrG-1::bla
ATM-10 V52 DrtxA DhlyA DhapA DvgrG-2b vgrG-1::bla
ATM-11 V52 DrtxA DhlyA DhapA vgrG-1DACD::blac
a Accessory toxin in-frame deletions as constructed in Tam et al., 2007.
b T6SS in-frame deletions as constructed in Pukatzki et al., 2006, 2007.
cNew deletions and fusions were constructed as described in Experi-
mental Procedures.
similarly transported into target cells
(Pukatzki et al., 2007). Thus, heterologous
proteindomains fused to theC terminusof
VgrG-1 might also be translocated in the
cytosol of target cells. Accordingly, we
constructed two strains that encode
fusions between endogenous vgrG-1 or
vgrG-1DACD and the blaM gene that
encodes b-lactamase enzyme (Bla).
b-lactamase activity can be measured using CCF2, a FRET
substrate that emits green fluorescence but emits blue fluores-
cence after cleavage by b-lactamase (Zlokarnik et al., 1998).
The Bla domain replaces the C-terminal ACD domain of VgrG-1
in strain ATM-11 and extends from the C terminus of the ACD in
strain ATM-7. This vgrG-1::bla gene was also introduced into
T6SS mutant backgrounds, creating strains ATM-8 (DvasK
vgrG-1::bla), ATM-9 (Dhcp vgrG-1::bla), and ATM-10 (DvgrG-2
vgrG-1::bla). All these strains produced b-lactamase fusion
proteins, but only VgrG-1-Bla and VgrG-1-DACD-Bla were
secreted in vitro by ATM-7 and ATM-11 (Figure 5A). Additionally,
secreted VgrG-1-Bla and VgrG-1-DACD-Bla were able to cleave
a freeacid formofCCF (Figure5B), indicatingb-lactamaseactivity
was intact in the fusion proteins. Extracellular transport of VgrG-
1-DACD-Bla also confirms that the ACD domain of VgrG-1 is
not required for secretion function of the T6SS apparatus.
We next tested whether VgrG-1-Bla fusion proteins could be
translocated into target cells. To monitor translocation of b-lac-
tamase, we used CCF2/AM, an esterified form of CCF2 that
accumulates in host cells and fluoresces green; after cleavage
by cytosolic b-lactamase, its product emits blue fluorescence
(Charpentier and Oswald, 2004; Marketon et al., 2005). In order
to optimize translocation into J774 cells, we took advantage of
the increased translocation elicited by treatment of cells with
bafilomycin A, observed earlier for the natural ACD reporter of
VgrG-1, and also treated host cells with a higher moi. After
J774 cells were incubated with various VgrG-1-Bla fusion
strains, translocation of b-lactamase into the cytosol was moni-
tored by quantitatively measuring substrate cleavage and by
fluorescence microscopy. All nonsecreting T6SS mutants had
CCF2/AMcleaved/uncleaved ratios similar tomock-treated cells
and incubations with ATM-1, which lacks the b-lactamase
fusion, while ATM-7 had a significantly higher cleaved/uncleaved
ratio, which was inhibited by cytochalasin D (Figure 5C).
Substrate cleavage in incubations with ATM-7 varied with moi
Cell Host & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevier Inc. 237
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Translocation of T6SS Effector Requires EndocytosisFigure 3. Cytochalasin D Inhibits Uptake into J774 Cells and In Vivo Actin Crosslinking
(A) Western blot against actin from J774 cells in the presence or absence of cytochalasin D. Exposure to V. cholerae was at an moi of 10 for 2 hr.
(B) Gentamicin protection assays were performed to verify inhibition of uptake. One hour exposure to V. cholerae at an moi of 10 was followed by gentamicin
treatment and enumeration of intracellular bacteria. Values are of triplicate wells and are expressed as percentage of initial inoculum recovered. Error bars
indicate ± one SD.
(C) In vitro actin-crosslinking assay with purified VgrG-1 and actin with various concentrations of cytochalasin D or 0.1%DMSO. After incubation at 37C for 1 hr,
reactions were ran out on a 4%–15% gradient SDS-PAGE gel and monitored by western blot.and bafilomycin A pretreatment time (Figures S1A and S1B).
Substrate cleavage was also monitored by fluorescence micros-
copy (Figure 5E).
ATM-11, which expresses and secretes VgrG-1-DACD-Bla, is
also able to translocate the b-lactamase fusion protein into host
cells and had a significantly higher cleaved/uncleaved ratio than
strain ATM-7. This could be due to an antiphagocytic effect
caused by the ACD of VgrG-1-Bla, which crosslinks actin in
host cells and thus inhibits subsequent uptake of bacterial cells
(Figure 5D). This antiphagocytic effect was observed after
shorter incubations with strain ATM-2, which produces RtxA
(Figure 2A), during which time robust actin crosslinking occurs.
However, with T6SS-mediated actin crosslinking, this effect
becomes apparent only after longer exposure to V. cholerae.
By eliminating the actin-crosslinking activity in strain ATM-11,
more bacteria are taken up into J774 cells over the course of
the incubation, and thus more intracellular bacteria are able to
translocate VgrG-1-DACD-Bla.
Opsonophagocytosis by CHO-FcgRII Cells
Todeterminewhether inductionofbacterial uptake intoanonpha-
gocytic cell line could stimulate translocation of VgrG-1 into an
otherwise resistant cell line, we used Chinese hamster ovary
(CHO) cells that express Fcg receptors (CHO-FcgRII), a cell line
which is engineered to induce opsonophagocytosis in an IgG-
dependent manner (Joiner et al., 1990). Gentamicin protection
assays show that uptake of ATM-1 and ATM-3 is significantly
higher than in incubations lacking opsonizing antibodies
(Figure 6A). Actin crosslinking occurs after exposure to ATM-1 in
the presence of anti-Vibrio antibody (Figure 6B), but not after
exposure to vasK mutant ATM-3. Similar to results seen with
J774 cells, cytochalasin D inhibited uptake of ATM-1 and ATM-3
and actin crosslinking induced by ATM-1 (Figures 6A and 6B).238 Cell Host & Microbe 5, 234–243, March 19, 2009 ª2009 ElsevieTranslocation into CHO-FcgRII cells was also monitored using
b-lactamase fusions to VgrG-1 and CCF2/AM substrate. Incuba-
tions with T6SS mutants expressing the VgrG-1-Bla fusion
protein had cleaved/uncleaved ratios similar to mock-treated
cells and incubation with ATM-1, a T6SS+ strain that lacks the
b-lactamase fusion. However, incubation with ATM-7 in the
presence of opsonizing antibodies had significantly higher
cleaved/uncleaved ratios, while incubation in the absence of op-
sonizing antibody had cleaved/uncleaved ratios similar to mock-
treated cells (Figure 6C). Cells were imaged, and CHO-FcgRII
cells emitted blue fluorescence when exposed to ATM-7 in the
presence of anti-Vibrio antibodies (Figure 6D), indicating cyto-
solic translocation of the C-terminal b-lactamase domain on
VgrG-1-Bla had occurred.
DISCUSSION
Bacterial pathogens utilize a variety of mechanisms to manipu-
late host cell function, and the actin cytoskeleton is a common
target (Barbieri et al., 2002). The ACD of RtxA toxin and VgrG-1
ofV. cholerae represent another biochemical paradigm formicro-
bial manipulation of actin function (Fullner and Mekalanos, 2000;
Kudryashov et al., 2008; Pukatzki et al., 2007). Detection of actin
crosslinking was a particularly useful tool to monitor T6SS func-
tion and allowed us to determine that bacterial endocytosis is
required for translocation into host cells. Even nonphagocytic
cell lines can be rendered sensitive to T6SS-mediated effects
by opsonophagocytosis of V. cholerae via expression of the
FcgRII receptor. This induced sensitivity is blocked by treatment
with cytochalasin D, suggesting that adherence of V52 to CHO-
FcgRII cells via IgG-FcgRII interaction is not sufficient to induce
translocation. Even without this artificial interaction, V52 and
derivative strains adhere to both phagocytic and nonphagocyticr Inc.
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Induced Actin Crosslinking in J774 Cells
(A) Time course of J774 cells exposed to ATM-1 at an
moi of 1 in the presence or absence of bafilomycin
A. Actin was visualized by western blot.
(B) Gentamicin protection assay of J774 in the pres-
ence or absence of bafilomycin A andwith the addition
of cytochalasin D. One hour long incubations at an
moi of 10 were followed by gentamicin treatment
and enumeration of intracellular bacteria. Values are
of triplicate wells and are expressed as percentage
of initial inoculum recovered. Error bars indicate ±
one SD. Values between different treatment condi-
tions are statistically significant by Student’s t test
(p < 0.05).
(C) Actin crosslinking in host cells in the presence
of 0.1% DMSO, bafilomycin A alone, or bafilomycin
A with cytochalasin D. Exposures were at moi of 10
and were 2 hr long. Actin was visualized by western
blot.
(D) In vitro actin-crosslinking assay with purified
VgrG-1 and actin with various concentrations of bafilo-
mycin A or 0.1% DMSO. After incubation at 37C for
1 hr, reactions were ran out on a 4%–15% gradient
SDS-PAGE gel and monitored by western blot.host cells (data not shown), suggesting that the correlation
between endocytic uptake and translocation is not due to
impaired interaction with the host cell surface. In contrast,
Legionella pneumophila can translocate type IV secretion effec-
tors into CHO-FcgRII cells at wild-type levels even in the pres-
ence of cytochalasin D, suggesting that membrane proximity
and/or adherence is sufficient to induce translocation (Cam-
bronne and Roy, 2007). This distinction suggests that the one
or more putative signals could trigger translocation within the
endosomeandmay represent a strategy to ensure that transloca-
tion occurs only in that specificmicroenvironment. It has yet to be
determined whether V. cholerae intracellular survival is affected
by the action of the ACD, or whether eventual escape from host
cells can occur after their actin cytoskeleton has been disrupted.
To some extent, this may depend on how fast the phagocytic cell
acidifies its endosome, orwhetherV. cholerae is phagocytosed in
a physiological state of comparable acid tolerance (Merrell and
Camilli, 1999). Since T6SS-dependent translocation of the ACD
requires close contact between bacterium and target cell, it
seems quite clear that this has not evolved as a mechanism to
disrupt the function of host cells at a distance, but rather plays
its predominant role in close cell-to-cell interactions. The endo-
cytosis requirement for T6SS suggests that phagocytes are the
natural target for V. cholerae T6SS, which could include preda-
tory phagocytes encountered in the environment or phagocytic
cells of the mammalian host immune system. T6SS-mediated
virulence mechanisms could function in both of these environ-
ments, similar to Legionella pneumophila virulence factors facili-
tating replication within both amoebae and humanmacrophages
(Swanson and Hammer, 2000). After uptake of V. cholerae by
J774 cells, T6SS mediates crosslinking of actin, which then
results in impaired phagocytic function and eventual host cellCell Hdeath. These effects could provide protection to bystander
V. cholerae within an infection of a mammalian host or within an
environmental reservoir. Indeed, interaction between V. cholerae
and free living aquatic amoebae Acanthamoeba castellani has
been reported (Abd et al., 2005). However, determining the bio-
logical role of the T6SS of V. cholerae will require other experi-
mental approaches and appropriate animal models that are
currently under development.
T6SS-mediated virulence targeted at phagocytes seems to be
a common theme for T6SS+ bacterial organisms, since many of
these phenotypes involve intracellular behavior or interaction
with phagocytes. Mutations in evpC, an hcp homolog, resulted
in reduced replication rates of Edwardsiella tarda in gourami
fish phagocytes (Rao et al., 2004). A homolog of IcmF, SciS,
from Salmonella typhimurium, is required for limiting intracellular
growth in macrophages (Parsons and Heffron, 2005). Compo-
nents of T6SS were reported to be upregulated in Burkholderia
pseudomallei after invasion of macrophages (Shalom et al.,
2007). These phenotypes and modes of regulation indicate that
signals in the endocytic compartment of host cells could trigger
the expression and function of T6SS systems in organisms other
than V. cholerae. The concept that T6SS-dependent virulence
factors are specialized for use in the endosomal microenviron-
ment is somewhat reminiscent of specialized T3SS loci that
function only after entry of bacteria into endosomes, as has
been observed in Salmonella species (Holden, 2002).
The results reported in this study indicate that the ACD of
VgrG-1 is not required for secretion in vitro or for translocation
into host cells, but is required for all known T6SS phenotypes
observed in V. cholerae incubation with eukaryotic cells. This
indicates that VgrG-1 is a bona fide effector of T6SS-dependent
cellular pathobiology rather than solely a component of the T6SSost & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevier Inc. 239
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1DACD-Bla into J774 Cells
(A) Western blot against b-lactamase of pellet and
supernatant fractions of various V52 strains producing
VgrG-1-Bla or VgrG-1DACD-Bla.
(B) InvitroCCF2-FAcleavagebysupernatantsofvarious
V52 strains grown in triplicate. Fluorescence was
measured with an excitation wavelength of 405 nm
and emission wavelengths of 460 nm (cleaved blue
channel) and 530 nm (uncleaved green channel). Values
are expressed as ratios of cleaved signal to uncleaved
signal. Error bars indicate ± one SD.
(C) Translocation of VgrG-1-Bla or VgrG-1DACD-Bla
into J774 cells incubated with various V52 strains.
Cells were pretreated with bafilomycin A, incubated
with V52 strains for 2 hr at an moi of 50, and then
loaded with CCF2/AM. Cells were harvested and
analyzed on a fluorescence plate reader as for
in vitro CCF2-FA assay. Ratios were normalized to
mock, and error bars indicate ± one SD.
(D) Gentamicin protection assay on host cells incu-
bated with V. cholerae as for translocation assay and
subsequently treated with gentamicin and enumera-
tion of intracellular bacteria. Values are of triplicate
wells and are expressed as percentage of initial inoc-
ulum recovered. Error bars indicate ± one SD.
(E) Fluorescence microscopy of J774 cells loaded with
CCF2/AM. Scale bar indicates 10 mm. ATM-7, ATM-8,
ATM-9, and ATM-10 all contain the vgrG-1-bla fusion
gene, and ATM-11 contains the vgrG-1-DACD-bla
gene.apparatus. Using b-lactamase fusions to VgrG-1, we demon-
strated T6SS-mediated intracellular delivery of an ectopic
reporter domain using the conserved ‘‘core’’ structure of VgrG-1.
Our data support a more general model for T6SS-mediated
delivery of effector domains located at the C termini of VgrG
orthologs. Over 500 VgrG orthologs are present in bacterial
genome sequence databases, and many of these VgrG ortho-
logs carry C-terminal extensions, some of which are predicted
to have interesting biochemical properties based on their struc-
tural similarity to other eukaryotic and prokaryotic proteins
(Pukatzki et al., 2007). Thus, these C-terminal domains could
be translocated into target cells only after phagocytosis of
bacteria capable of expressing a functional T6SS. However,
not all T6SS+ organisms contain VgrGs with putative C-terminal
effector domains, suggesting that there may be T6SS effectors
that are not VgrG orthologs (Pukatzki et al., 2009). It remains
to be determined whether VgrG proteins possess innate translo-
cation activity or can serve also as a channel for translocation of
other effectors. Attempts to show that secreted VgrG-1 and Hcp
proteins display cytotoxicity for phagocytic cells have so far
failed (Pukatzki et al., 2006), although it is possible that such
secreted complexes are capable of mediating translocation of
the ACD only in the microenvironment of the endosomal lumen.
Because the well-conserved core of VgrG-related proteins is
predicted to form a trimeric needle-like complex that resembles
bacteriophage T4 tail spike, a membrane penetrating device, it is240 Cell Host & Microbe 5, 234–243, March 19, 2009 ª2009 Elseviepossible that VgrG proteinsmight play an active role in breaching
the target cellmembrane. In themodel of T4bacteriophage infec-
tion of E. coli, the force generated from conformational changes
in the base plate and contraction of the tail sheath drives the tail
tube and tail spike through host cell membrane (Kostyuchenko
et al., 2005). In addition to VgrG, there are other T6SS proteins
that are structurally similar to bacteriophage tail components.
The structure of Hcp resembles bacteriophage tail tube proteins
of bacteriophage T4 and lambda (Leiman et al., 2009; Pell et al.,
2009). Another T6SS protein resembles gp25, a bacteriophage
T4 tail protein that is present at the interface of the tail tube and
tail spike (Leiman et al., 2009). Given the mechanism by which
T4 bacteriophage infects host cells and the structural similarities
between components of T6SS and T4 bacteriophage tail, we
favor a model in which T6SS-dependent phenotypes truly reflect
the activity of a T6SS membrane-penetrating, translocation
machine rather than simply extracellular secretion within the en-
dosomal compartment. Mechanistic studies of the structure and
function of the bacterial associated T6SS core complex and
mechanism of translocation are needed to test this model.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Cell Culture
Vibrio cholerae strains were grown in Luria-Bertani (LB) broth supplemented
with 100 mg/ml streptomycin. In-frame deletions and b-lactamase fusionsr Inc.
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FcRgII Cells Induces Translocation of
VgrG-1
(A) Gentamicin protection assay of CHO-FcgRII
cells incubated with various V52 strains in the
presence or absence of a-Vibrio antibody and
with cytochalasin D. Values are expressed as
percentage of initial inoculum recovered, and error
bars indicate ± one SD. Groupsmarkedwith aster-
isks are significantly higher than remaining groups
(Student’s t test, p < 0.05).
(B) Western blot against actin from CHO-FcgRII
cells incubated with various V52 strains at an moi
of 50 for 30 min under various conditions, then
treated with gentamicin for an additional 1.5 hr.
Actin was visualized by western blot.
(C) Translocation of VgrG-1-Bla into CHO-FcgRII
cells by various V52 strains. Cells were pretreated
with a-Vibrio antibody, incubated with V. cholerae
at anmoi of 50 for 2 hr, loadedwith CCF2/AM, then
harvested for quantification. Fluorescence was
measuredwith an excitationwavelength of 405 nm
and emission wavelengths of 460 nm (cleaved
blue channel) and 530 nm (uncleaved green
channel). Values are expressed as ratios of
cleaved signal to uncleaved signal and are normal-
ized to mock. Error bars indicate ± one SD.
(D) Fluorescence microscopy of CHO-FcgRII cells
incubatedwith various V52 strains and then loaded
with CCF2/AM. Scale bar indicates 10 mm. ATM-7,
ATM-8, ATM-9, andATM-10 all encode vgrG-1-bla
fusion gene.were introduced into V52 using previously described methods (Skorupski and
Taylor, 1996). In-frame deletions of accessory toxins rtxA, hlyA, and hapAwere
constructed as in Tam et al., 2007. In-frame deletions of T6SS components
vasK, hcp-1, hcp-2, vgrG-1, and vgrG-2 were constructed as in Pukatzki
et al., 2006 and 2007. Strain ATM-6 was constructed by allelic exchange of
vgrG-1DACD-VSV-G, which encodes amino acids 1–715 of VgrG-1 fused to
VSV-G epitope tag. The blaM gene encodes a TEM-1-type b-lactamase and
was cloned from pVTM30 (Tam et al., 2007) to produce vgrG-1::bla fusion
gene, whichwas introduced into ATM-7, ATM-8, ATM-9, and ATM-10 by allelic
exchange. Strain ATM-11 was constructed similarly with vgrG-1DACD::bla. All
resulting strains are listed in Table 1. J774, RAW264.7, NIH 3T3, and CHO-
FcgRII cells weremaintained in DMEM. HEp-2 and A549 cells weremaintained
in RPMI 1640. Henle-407 cells were maintained in EMEM. All media were sup-
plemented with 2 mM L-glutamine, penicillin at 100 U/ml, 100 mg/ml strepto-
mycin, and 10% heat-inactivated FBS. Cells were maintained at 37C and
5% CO2.
In Vitro Secretion Assay
Various bacterial strains were back-diluted 1:50 into LB broth from overnight
cultures. Cultures were grown for approximately 2 hr on a roller drum at
37C. Pellet fractions were collected and concentrated 2-fold in LDS loading
buffer (Invitrogen; Carlsbad, CA). Supernatants were filtered, precipitated
with trichloroacetic acid, and resuspended in LDS loading buffer, resulting in
a 100-fold concentration, except for a-Hcp western blots, which were not
concentrated. VSV-G antibody was obtained from Sigma-Aldrich (St. Louis).
RNAP a-subunit antibody was obtained fromNeoclone (Madison, WI). b-lacta-
mase antibody was obtained from Abcam (Cambridge, MA). VgrG-1, VgrG-2,
VgrG-3, and Hcp polyclonal antibodies were generated by New England
Peptide (Gardner, MA). Synthetic peptides encoding unique amino acid
sequences of Hcp-1, VgrG-1, VgrG-2, and VgrG-3 were prepared and conju-
gated to keyhole limpet hemocyanin. The conjugated peptides were injected
into New Zealand white rabbits, boosted twice, and then tested on crude
cell extracts and culture supernatants from Vibrio cholerae V52 and corre-
sponding mutants by western blot to ensure specificity.Cell HIn Vitro b-Lactamase Activity Assay
Bacteriawere grown in triplicate cultures as for in vitro secretion assays. CCF2-
FA (Invitrogen) was added to cell-free supernatant fractions, and the mixture
was incubated in the dark for 30 min at room temperature. Fluorescence was
quantified on a SpectraMax Gemini XS fluorescent plate reader with an excita-
tion wavelength of 405 nm and emission wavelengths of 460 nm (cleaved blue
channel) and 530 nm (uncleaved green channel). Values were corrected for
LB blank readings and expressed as a ratio of cleaved to uncleaved signal.
Dictyostelium discoideum Plaque Assay
One hundred microliters of overnight bacterial cultures were plated with
dilutions of Dictyostelium discoideum on SM/5 plates as previously described
(Pukatzki et al., 2007). Plates were incubated at 22C for 3 days before plaque
formation was assessed. For quantification, bacterial strains were plated in
triplicate, and the number of plaques was normalized to plaques formed on
K. aerogenes lawns.
Incubation with Host Cells
Host cells were seeded in 12-well plates at a density of 1–2 3 105 per well
in drug-free media. The next day, cells were pretreated with 0.1% DMSO,
5 mg/ml cytochalasin D, or 100 nM bafilomycin A for 1 hr unless otherwise indi-
cated. Triplicate incubations were performed at an moi of 10 unless otherwise
indicated. For gentamicin protection assays, incubations were allowed to
proceed for 1 hr, followed by 1 hr treatment with 100 mg/ml gentamicin. Host
cells were washed with PBS, lysed with 1% saponin, and plated for colony-
forming units on LB agar plates. For detection of in vivo actin crosslinking,
incubations were allowed to proceed for 2 hr, unless otherwise indicated.
Host cells were harvested, pooled, and resuspended in LDS loading buffer (In-
vitrogen) for analysis by western blot using a-actin antibody (Sigma-Aldrich).
CHO-FcgRII Cells
CHO-FcgRII cells were incubated with 1:100 anti-Vibrio antibody (Tam et al.,
2007) for at least 1 hr before incubation with V. cholerae. Bacteria were
added at an moi of 10 for gentamicin protection assays or an moi of 50 forost & Microbe 5, 234–243, March 19, 2009 ª2009 Elsevier Inc. 241
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Cells were incubated with V. cholerae for 30 min at 37C, then treated with 100
mg/ml gentamicin for 1.5 hr. Cells were washed with PBS, lysed with 1%
saponin, and plated at LB agar plates to enumerate colony-forming units.
Alternatively, cells were harvested for western blot analysis of actin.
Translocation Assay
Host cells were seeded as described above. For fluorescence microscopy
experiments, cellswere seeded into glass-bottom12-well plates (MatTek; Ash-
land, MA). J774 cells were pretreated with 100 nM bafilomycin A (Sigma-Al-
drich) for 4 hr, then incubated with various V52 strains at an moi of 50 for 2 hr.
CHO-FcgRII cells were incubated as described above for actin-crosslinking
assays, except incubations were allowed to proceed for 2 hr. Host cells were
then washed with PBS and loaded with CCF2-AM for 1 hr. For fluorescence
microscopy, images were acquired with a Nikon inverted epifluorescence
microscope. For quantification by fluorescence plate reader, cells were
washed after CCF2-AM loading, then allowed to incubate for an additional
30min. Cells were then harvested in 100 ml HBSS and transferred to an opaque
96-well plate, and fluorescencewas quantified as described for in vitro b-lacta-
mase activity assay.
LDH Release Assay
J774 cells were incubated with various bacterial strains in triplicate at an moi of
10 for 2hr, atwhich timewellswerewashedwithPBSand treatedwith100mg/ml
gentamicinovernight. Thenextday, supernatantsamplesor lysedmock-treated
cells were collected and analyzedwith cytotoxicity detection kit (Roche Applied
Science; Indianapolis, IN). Values are expressed aspercentage of LDH released
from lysed mock-treated wells.
Visualization of Actin Cytoskeleton by Fluorescence Microscopy
J774 cells were seeded onto glass-bottom 12-well plates (MatTek). The next
day, J774 cells were incubated with various bacterial strains at an moi of 10 for
2 hr, at which time wells were washed with PBS and fixed with 3.7% parafor-
maldehyde. Cells were permeabilized with 0.1% Triton X, stained with rhoda-
mine phalloidin (Invitrogen) and DAPI (Sigma-Aldrich), and mounted. Images
were acquired on a Nikon inverted epifluorescence microscope.
In Vitro Actin-Crosslinking Assay
This assay was performed as previously described (Cordero et al., 2006;
Pukatzki et al., 2007), except for the addition of DMSO, cytochalasin D, or
bafilomycin A at the concentrations indicated. Actin derived from rabbit
skeletal muscle (Cytoskeleton; Denver) was used as substrate for in vitro
crosslinking reactions that were incubated at 37C for 1 hr.
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